staurosporine aglycone has been researched along with Stroke in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qi, D | 1 |
Ouyang, C | 1 |
Wang, Y | 1 |
Zhang, S | 1 |
Ma, X | 1 |
Song, Y | 1 |
Yu, H | 1 |
Tang, J | 1 |
Fu, W | 1 |
Sheng, L | 1 |
Yang, L | 1 |
Wang, M | 1 |
Zhang, W | 1 |
Miao, L | 1 |
Li, T | 1 |
Huang, X | 1 |
Dong, H | 1 |
1 other study available for staurosporine aglycone and Stroke
Article | Year |
---|---|
HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke.
Topics: Animals; Apoptosis; Brain Ischemia; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Carb | 2014 |